Study of BC3402 in Combination With Azacitidine in Patients With MDS and CMML

NCT05970822 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

32

Enrollment

INDUSTRY

Sponsor class

Conditions

Myelodysplastic Syndromes
Chronic Myelomonocytic Leukemia

Interventions

DRUG: BC3402
DRUG: Azacitidine

Sponsor

Biocity Biopharmaceutics Co., Ltd.